Skip to main content
Premium Trial:

Request an Annual Quote

SAEC, Cerner to Study Genetic Markers for Adverse Drug Effects

NEW YORK (GenomeWeb News) – The International Serious Adverse Events Consortium said last week that it will collaborate with electronic medical records provider Cerner on identifying genetic markers to help predict individuals who are at risk for a range of serious drug-related adverse events.
The consortium, which was founded a year ago, said it will explore the feasibility of diversifying its methods for developing serious adverse event research cohorts. The alliance with Cerner will focus on three SAEs: hepatoxicity, serious skin rashes, and cardiac dysfunctions, such as prolonged QT.
“By working with third party EMR providers such as Cerner, we hope to open up a new, more scalable research channel to enroll subjects into this vital research,” Arthur Holden, chairman of the SAEC, said in a statement. “Our goal is to increase the breadth and diversity of patients participating and to provide our clinical research collaborators with larger, more developed research cohorts in a more efficient and effective manner.”

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.